Related Guides
Deeper context, comparisons, and practical research paths.
Herb Profile
Myristica fragrans
Myristica Fragrans (Myristica fragrans) carries a Grade C rating — limited evidence.
Use extra caution — High dose nutmeg/myristicin exposure can cause neuropsychiatric and cardiovascular toxicity. Details
Continue reading
Safety
High dose nutmeg/myristicin exposure can cause neuropsychiatric and cardiovascular toxicity.
High caution
Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.
Evidence-based safety
Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.
Blood-pressure effects · Sedation / CNS depression
Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.
Data provenance recorded for 81 of 81 pairings in this mechanism group.
+69 more pairings share this mechanism. Use the Safety Checker to review a specific combination.
Data provenance recorded for 68 of 68 pairings in this mechanism group.
+56 more pairings share this mechanism. Use the Safety Checker to review a specific combination.
Evidence
Read as directional context, not settled clinical proof.
Human clinical evidence: Present in source signals
Mechanistic / preclinical: Mechanism mapped — Neurotransmitter Modulation
Research maturity: Emerging research — Long Term Human Evidence May Be Limited.
Safety boundary: Safety note available — High dose nutmeg/myristicin exposure can cause neuropsychiatric and cardiovascular toxicity.
This profile cites 3 human studies.
Evaluation of methodological rigor, population reach, and evidence alignment.
Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.
Filter by study class
Showing 5 of 5 studies.
What the evidence actually shows
This table contains 5 structured sources, including 1 human evidence source; 0 are human trials. A reliable participant total cannot be calculated because sample size is not consistently structured in the cited sources. Source-to-conclusion relationships are not classified in this structured set, so consistency is not yet classifiable.
Profile-wide evidence grade: see the profile grade above · Confidence: not separately assigned
What would change our conclusion?
Larger, well-controlled human trials using comparable populations, doses, preparations, and clinically meaningful outcomes could materially strengthen or weaken this conclusion. Replication in a different population or a high-quality synthesis resolving current disagreement could also materially change confidence.
| Study | Design | N | Dose | Duration | Population | Outcome | Result & magnitude | Source |
|---|---|---|---|---|---|---|---|---|
Background | Systematic review Uses a predefined method to find and evaluate relevant studies, but may or may not pool their results statistically. | — | — | — | — | — | A 2025/2026 systematic review of medicinal/edible seed safety identified 703 adverse events across eight seed medicines; Myristicae semen contributed one serious adverse event. Most events across the dataset involved children or excessive intake. These counts do not establish nutmeg-specific incidence but strengthen overdose/child-safety warnings. | PubMed → |
Ashokkumar K et al. · Phytother Res · 2022 Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | — | PubMed → |
PubMed indexed authors · 2006 Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | — | PubMed → |
Phytochemical and pharmacological properties of Myristica fragrans Houtt.: an updated review Ha MT et al. · Arch Pharm Res · 2020 Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | — | PubMed → |
Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | A toxicology review documents neuropsychiatric and autonomic intoxication after gram-level nutmeg ingestion. These reports are toxicity observations—not a safe-use threshold—and support explicit overdose/intoxication warnings. | PubMed → |
Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.
Mechanism Pathway — How Myristica Fragrans Works
Preclinical pathways. Proposed mechanisms from in vitro and animal research; these do not confirm clinical outcomes in humans.
Key constituents studied in Myristica Fragrans, with full pharmacology and safety profiles.
Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.
Condition guides
Compare side-by-side tradeoffs or verify active marker guidelines.
Independent database mapping — evaluated separately from safety and efficacy scores.
Affiliate disclosure: Shopping links may earn this site a commission at no cost to you. Links are chosen on quality and availability, never commission tiers; safety warnings and evidence ratings stay independent.
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.
Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.
Help improve this profile
These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.
Was this evidence summary clear?
Did you find what you were researching?
Free safety checklist
Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.
Botanical profile context
Myristica Fragrans herb profile with evidence context, key research topics, source notes, safety context, and references presented in an evidence-first… Use this herb profile as a starting point for evidence review, not as a recommendation to start a new supplement. Botanical products can vary by plant part, extract ratio, standardization, dose, and contaminant testing, so two labels with the same common name may not behave the same way.
When reviewing Myristica Fragrans, compare the traditional-use context against the human evidence, mechanism notes, and safety cautions. Pay special attention to pregnancy, breastfeeding, liver or kidney disease, blood-pressure effects, sedation, stimulation, anticoagulant use, antidepressants, and any prescription medication overlap.
For product decisions, prefer transparent labels, named extracts, clear serving sizes, and third-party quality testing. Avoid treating a long list of possible mechanisms as proof that an herb will solve a specific condition.